Brief: Chemometec Posts Q3 Revenue of DKK 105.4 Million
08/05/2023 16:51
May 8 (Reuters) - Chemometec Q3 EBITDA margin 53%. * Outlook FY EBITDA DKK 245-260 million * Q3 EBITDA DKK 56.3 million * Q3 revenue DKK 105.4 million * Outlook FY revenue in the DKK 430-460 million range
Recent news on ChemoMetec A/S
See all newsDenmark's Chemometec Q1 revenue rises 28% on instrument sales
Brief: Chemometec Q1 EBITDA DKK 100.3 Million
Denmark's ChemoMetec lifts FY outlook on strong instrument demand, lower costs
Brief: Chemometec Raises 2026/27 EBITDA Guidance To DKK 335-360 Million
Brief: Chemometec A/S Says Board Initiates Share Buy-Back Based On AGM Authorisation